| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 83,843 | 80,913 | ||
| General and administrative | 28,853 | 23,658 | ||
| Total operating expenses | 112,696 | 104,571 | ||
| Loss from operations | -112,696 | -104,571 | ||
| Change in fair value of related party revenue share liability | -19,810 | -6,040 | ||
| Interest income and other income (expense), net | 10,201 | 11,103 | ||
| Total other income (expense), net | -9,609 | 5,063 | ||
| Loss before income taxes | -122,305 | -99,508 | ||
| Income tax provision | 132 | 145 | ||
| Net loss | -122,437 | -99,653 | ||
| Unrealized gains on marketable securities | 1,007 | 509 | ||
| Comprehensive loss | -121,430 | -99,144 | ||
| Net loss per share attributable to class a and class b common stockholders, basic | -1.7 | -1.39 | ||
| Net loss per share attributable to class a and class b common stockholders, diluted | -1.7 | -1.39 | ||
| Weighted average number of shares outstanding, diluted | 72,143,466 | 71,843,774 | ||
| Weighted average shares of class a and class b common stock outstanding, basic | 72,143,466 | 71,843,774 | ||
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)